menu search

A big day for transglobe energy

The new contract was finally approved. The stocked soared on the news....

February 13, 2022, 8:56 am

A big day for transglobe energy

The new contract was finally approved. The stocked soared on the news....

February 13, 2022, 8:56 am

A big day for transglobe energy

The new contract was finally approved. The stocked soared on the news....

February 13, 2022, 8:56 am

Microsoft tries to win over regulators for its massive activision blizzard deal

Microsoft is trying to persuade regulators to approve its $68.7 billion acquisition of Activision Blizz...

February 9, 2022, 2:24 pm

Microsoft tries to win over regulators for its massive activision blizzard deal

Microsoft is trying to persuade regulators to approve its $68.7 billion acquisition of Activision Blizz...

February 9, 2022, 2:24 pm

Microsoft tries to win over regulators for its massive activision blizzard deal

Microsoft is trying to persuade regulators to approve its $68.7 billion acquisition of Activision Blizz...

February 9, 2022, 2:24 pm

Pfizer ceo says chances are 'very high' fda will approve low-dose covid shots for kids under 5

"I think the chances are very high FDA to approve it," Bourla told CNBC, saying he believes the agency ...

February 8, 2022, 2:18 pm

Pfizer ceo says chances are 'very high' fda will approve low-dose covid shots for kids under 5

"I think the chances are very high FDA to approve it," Bourla told CNBC, saying he believes the agency ...

February 8, 2022, 2:18 pm

Pfizer ceo says chances are 'very high' fda will approve low-dose covid shots for kids under 5

"I think the chances are very high FDA to approve it," Bourla told CNBC, saying he believes the agency ...

February 8, 2022, 2:18 pm

Mydecine innovations says its exclusive dealer identified as licensed psilocybin and mdma supplier in canada

Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) announced that Health Canada has included the dealer's license the company operates under as a su...

February 8, 2022, 8:32 am

Mydecine innovations says its exclusive dealer identified as licensed psilocybin and mdma supplier in canada

Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) announced that Health Canada has included the dealer's license the company operates under as a su...

February 8, 2022, 8:32 am

Mydecine innovations says its exclusive dealer identified as licensed psilocybin and mdma supplier in canada

Mydecine Innovations Group Inc (OTC:MYCOF, NEO:MYCO) announced that Health Canada has included the dealer's license the company operates under as a su...

February 8, 2022, 8:32 am

Yum! brands hikes dividend by 14%

Yum! Brands, Inc. (NYSE: YUM) Board of Directors has approved a 14% increase in its quarterly dividen...

February 8, 2022, 5:21 am

Yum! brands hikes dividend by 14%

Yum! Brands, Inc. (NYSE: YUM) Board of Directors has approved a 14% increase in its quarterly dividen...

February 8, 2022, 5:21 am

Yum! brands hikes dividend by 14%

Yum! Brands, Inc. (NYSE: YUM) Board of Directors has approved a 14% increase in its quarterly dividen...

February 8, 2022, 5:21 am

G1 therapeutics: biotech with fda approved drug plus additional potential

Cosela is an FDA-approved myelosuppressive agent given before chemotherapy in patients with extensive-stage small cell lung cancer. Cosela may potenti...

February 7, 2022, 10:07 pm

G1 therapeutics: biotech with fda approved drug plus additional potential

Cosela is an FDA-approved myelosuppressive agent given before chemotherapy in patients with extensive-stage small cell lung cancer. Cosela may potenti...

February 7, 2022, 10:07 pm

G1 therapeutics: biotech with fda approved drug plus additional potential

Cosela is an FDA-approved myelosuppressive agent given before chemotherapy in patients with extensive-stage small cell lung cancer. Cosela may potenti...

February 7, 2022, 10:07 pm

Sanofi's (sny) enjaymo gets fda nod for rare blood disorder

The FDA approves Sanofi's (SNY) Enjaymo for the treatment of hemolysis in adult patients with cold aggl...

February 7, 2022, 2:39 pm

Sanofi's (sny) enjaymo gets fda nod for rare blood disorder

The FDA approves Sanofi's (SNY) Enjaymo for the treatment of hemolysis in adult patients with cold aggl...

February 7, 2022, 2:39 pm


Search within

Pages Search Results: